Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/08/2009US20090252762 novel proteosome-liposaccharide vaccine adjuvant
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252760 Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3
10/08/2009US20090252759 Immunogenic composition
10/08/2009US20090252756 Protein-based streptococcus pneumoniae vaccines
10/08/2009US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV
10/08/2009US20090252754 Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses
10/08/2009US20090252753 Immunomodulation for autoimmune type-2 diabetes
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252751 Immune adjuvant comprising ubiquinone
10/08/2009US20090252750 Antibodies and immunotoxins that target human glycoprotein nmb
10/08/2009US20090252749 Compositions and Methods for Producing a Composition
10/08/2009US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252746 Erythropoietin receptor binding antibodies
10/08/2009US20090252745 Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
10/08/2009US20090252744 Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252742 IL3Ralpha antibody conjugates and uses thereof
10/08/2009US20090252741 Human monoclonal anti-ctla4 antibodies in cancer treatment
10/08/2009US20090252740 Method for Predicting Responsiveness to TNF Alpha Blocking Agents
10/08/2009US20090252739 Cerebral Infarction Suppressant
10/08/2009US20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252736 Mammalian Genes; Related Reagents
10/08/2009US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009US20090252734 Antihuman alpha 9 Integrin Antibody and use of the Same
10/08/2009US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009US20090252732 Variable region sequences of il-31 monoclonal antibodies and methods of use
10/08/2009US20090252731 Multivalent Carriers of Bi-Specific Antibodies
10/08/2009US20090252730 Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia aereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus; conjugated to polyoxyethylene glycol, serum albumin
10/08/2009US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252727 Glucagon receptor antagonists
10/08/2009US20090252726 Antibodies for inhibiting blood coagulation and methods of use thereof
10/08/2009US20090252725 Use of CD23 Antibodies to Treat Malignancies in Patients with Poor Prognosis
10/08/2009US20090252724 Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region
10/08/2009US20090252723 Remedy for endometriosis
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252721 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
10/08/2009US20090252683 Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof
10/08/2009US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR
10/08/2009CA2720513A1 Non-invasive systems and methods for in-situ photobiomodulation
10/08/2009CA2720368A1 Her2/neu-specific antibodies and methods of using same
10/08/2009CA2720359A1 Liver cancer drug
10/08/2009CA2720294A1 Assay for soluble cd200
10/08/2009CA2720277A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009CA2720166A1 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
10/08/2009CA2720025A1 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis
10/08/2009CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009CA2719252A1 Anti-infective agents and uses thereof
10/08/2009CA2718184A1 Agent for treating disease
10/07/2009EP2107374A1 Polypeptide for diagnosis of vaccination
10/07/2009EP2107115A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
10/07/2009EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2107071A2 Anti-EpCAM immunoglobulins
10/07/2009EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009EP2106803A1 Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
10/07/2009EP2106802A1 Modified peptides as synthetic vaccines in amyloid-associated disease
10/07/2009EP2106801A1 IL-25 for use in the treatment of inflammatory diseases
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106442A1 Cancerous disease modifying antibodies
10/07/2009EP2106441A1 Cancerous disease modifying antibodies
10/07/2009EP2106262A1 Novel prostate kallikrein allergen
10/07/2009EP2106261A2 Antagonists of pcsk9
10/07/2009EP1617216B1 Novel method of screening
10/07/2009EP1584627B1 Dimerized peptide
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009EP1317285B1 Methods for treating demyelinating diseases
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis
10/07/2009EP1053329B1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009CN101553728A The use of Granulin-Epithelin Precursor (GEP) antibodies for detection and suppression of Hepatocellular carcinoma (HCC)
10/07/2009CN101553506A LINGO binding molecules and pharmaceutical use thereof
10/07/2009CN101553504A Abeta antibody parenteral formulation
10/07/2009CN101553502A Hemagglutinin polypeptides, and reagents and methods relating thereto
10/07/2009CN101553259A Cytotoxicity mediation of cells evidencing surface expression of CD63
10/07/2009CN101553255A Smallpox monoclonal antibody
10/07/2009CN101553254A Use of TGF-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
10/07/2009CN101553253A Combination of ZD6474 and bevacizumab for cancer therapy
10/07/2009CN101553252A Vaccines including antigen from four strains of influenza virus
10/07/2009CN101553251A Immunisation method against the 4 dengue serotypes
10/07/2009CN101553250A Apparatus and method for vaccine development using ultrasound technology
10/07/2009CN101553249A Vaccines for malaria
10/07/2009CN101553248A Novel H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
10/07/2009CN101553247A Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods
10/07/2009CN101553246A Protein matrix vaccines and methods of making and administering such vaccines
10/07/2009CN101553245A Compositions for reprogramming a cell and uses therefor
10/07/2009CN101553244A Treatment for intimal hyperplasia and related conditions
10/07/2009CN101553233A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/07/2009CN101553232A Kinase inhibitors useful for the treatment of proliferative diseases
10/07/2009CN101550192A Monoclonal antibody K42-D2 of antihuman granzyme K and hybridoma cell line for excreting same
10/07/2009CN101550191A Malignant melanoma T cell nano antibody, coding sequence and application thereof
10/07/2009CN101550190A An anti-il-12 antibody, a composition, a method and the function
10/07/2009CN101550189A Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/07/2009CN101550188A H5 subtype bird-flue virus H5N1 hemagglutinin monoclonal antibody and nucleic acid sequence and preparation method thereof
10/07/2009CN101550182A Swine hepatitis E virus epitope and application thereof
1 ... 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 ... 1823